So, what does microdosing GLP-1s look like
Transport przez PepT1 o jelitowa
Common GI Side Effects Nausea, vomiting, diarrhea, constipation, abdominal pain, distension, dyspepsia, flatulence, and belching hit up to 50% of users during dose escalation
chrysops female)
In the STEP 1 trial: Participants who took the medication lost an average of 14.9% of their body weight over 68 weeks By comparison, those who received a placebo lost only 2.4% Nearly 86% of GLP-1 users lost at least 5% of their body weight, an important clinical marker Additional real-world data backs this up
Caffeine and Alcohol Drinking alcohol, soda, or coffee within a few hours of bedtime can disrupt sleep